Works matching Human papillomavirus (HPV) vaccine

Results: 1706
    1
    2

    962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016.

    Published in:
    Open Forum Infectious Diseases, 2019, v. 6, p. S29, doi. 10.1093/ofid/ofz359.064
    By:
    • Gargano, Julia;
    • Lewis, Rayleen;
    • Hunt, Hillary;
    • McClung, Nancy;
    • Bennett, Nancy M;
    • Griffin, Marie;
    • Niccolai, Linda;
    • Park, Ina;
    • Powell, Melissa;
    • Brackney, Monica;
    • Scahill, Mary;
    • Pemmaraju, Manideepthi;
    • Fink, Deanna;
    • Ehlers, Sara;
    • Cleveland, Angela;
    • Unger, Elizabeth R;
    • Markowitz, Lauri
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Response to: Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions.

    Published in:
    2020
    By:
    • Barboi, Alexandru;
    • Gibbons, Christopher H.;
    • Bennaroch, Eduardo E.;
    • Biaggioni, Italo;
    • Chapleau, Mark W.;
    • Chelimsky, Gisela;
    • Chelimsky, Thomas;
    • Cheshire, William P.;
    • Claydon, Victoria E.;
    • Freeman, Roy;
    • Goldstein, David S.;
    • Joyner, Michael J.;
    • Kaufmann, Horacio;
    • Low, Phillip A.;
    • Norcliffe-Kaufmann, Lucy;
    • Robertson, David;
    • Shibao, Cyndya A.;
    • Singer, Wolfgang;
    • Snapper, Howard;
    • Vernino, Steven
    Publication type:
    Letter
    17
    18
    19
    20
    21

    American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors.

    Published in:
    CA: A Cancer Journal for Clinicians, 2007, v. 57, n. 1, p. 7
    By:
    • Saslow, Debbie;
    • Castle, Philip E.;
    • Cox, J. Thomas;
    • Davey, Diane D.;
    • Einstein, Mark H.;
    • Ferris, Daron G.;
    • Sue J. Goldie;
    • Harper, Diane M.;
    • Kinney, Walter;
    • Moscicki, Anna-Barbara;
    • Noller, Kenneth L.;
    • Wheeler, Cosette M.;
    • Ades, Terri;
    • Andrews, Kimberly S.;
    • Doroshenk, Mary K.;
    • Kahn, Kelly Green;
    • Schmidt, Christy;
    • Shafey, Omar;
    • Smith, Robert A.;
    • Partridge, Edward E.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study.

    Published in:
    Clinical Infectious Diseases, 2017, v. 64, n. 7, p. 852, doi. 10.1093/cid/ciw865
    By:
    • Zheng Quan Toh;
    • Russell, Fiona M.;
    • Reyburn, Rita;
    • Fong, James;
    • Tuivaga, Evelyn;
    • Ratu, Tupou;
    • Nguyen, Cattram D.;
    • Devi, Rachel;
    • Kama, Mike;
    • Matanitobua, Silivia;
    • Tabrizi, Sepehr N.;
    • Garland, Suzanne M.;
    • Sinha, Rohit;
    • Frazer, Ian;
    • Tikoduadua, Lisi;
    • Kado, Joseph;
    • Rafai, Eric;
    • Mulholland, Edward K.;
    • Licciardi, Paul V.
    Publication type:
    Article
    36
    37
    38
    39
    40

    A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 743, doi. 10.1007/s00262-020-02720-7
    By:
    • Chandra, J.;
    • Woo, W. P.;
    • Finlayson, N.;
    • Liu, H. Y.;
    • McGrath, M.;
    • Ladwa, R.;
    • Brauer, M.;
    • Xu, Y.;
    • Hanson, S.;
    • Panizza, B.;
    • Frazer, I. H.;
    • Porceddu, Sandro V.
    Publication type:
    Article
    41
    42
    43
    44

    Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.

    Published in:
    International Journal of Cancer, 2012, v. 131, n. 1, p. 106, doi. 10.1002/ijc.26362
    By:
    • Szarewski, A.;
    • Poppe, W.A.J.;
    • Skinner, S.R.;
    • Wheeler, C.M.;
    • Paavonen, J.;
    • Naud, P.;
    • Salmeron, J.;
    • Chow, S.-N.;
    • Apter, D.;
    • Kitchener, H.;
    • Castellsagué, X.;
    • Teixeira, J.C.;
    • Hedrick, J.;
    • Jaisamrarn, U.;
    • Limson, G.;
    • Garland, S.;
    • Romanowski, B.;
    • Aoki, F.Y.;
    • Schwarz, T.F.;
    • Bosch, F.X.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50